Optipen


Combined with:

Lantus

Indications and Reactions:

Role Indications Reactions
Secondary
Type 2 Diabetes Mellitus 21.0%
Hypertension 18.1%
Type 1 Diabetes Mellitus 10.9%
Diabetes Mellitus 10.3%
Prophylaxis 8.2%
Blood Pressure 6.9%
Device Therapy 2.9%
Gastric Disorder 2.9%
Hypothyroidism 2.9%
Myocardial Infarction 2.5%
Renal Disorder 1.9%
Thyroid Disorder 1.9%
Cardiovascular Disorder 1.5%
Depression 1.5%
Pain 1.5%
Cardiovascular Event Prophylaxis 1.3%
Anticoagulant Therapy 1.1%
Vitamin Supplementation 1.1%
Anxiety 0.8%
Coronary Artery Disease 0.8%
Vomiting 9.1%
Hyperglycaemia 6.5%
Pneumonia 6.5%
Weight Decreased 6.5%
Dementia Alzheimer's Type 5.2%
Mental Status Changes 5.2%
Pain In Extremity 5.2%
Rectosigmoid Cancer Stage Iii 5.2%
Renal Impairment 5.2%
Vision Blurred 5.2%
Visual Impairment 5.2%
Drug Exposure During Pregnancy 3.9%
Feeling Abnormal 3.9%
Injection Site Pain 3.9%
Non-small Cell Lung Cancer 3.9%
Pancreatic Carcinoma 3.9%
Prostate Cancer 3.9%
Renal Failure Chronic 3.9%
Somnolence 3.9%
Speech Disorder 3.9%
Concomitant
Blood Pressure 30.0%
Type 2 Diabetes Mellitus 30.0%
Device Therapy 20.0%
Diabetes Mellitus 20.0%
Blindness 50.0%
Tremor 50.0%

Drug Data